H
Hyatt Hotels Corporation
H has lower modeled downside risk, despite its lower overall score.
LCID
Lucid Group, Inc.
LCID has a slight edge over H overall, supported by stronger valuation and stronger fundamentals.
H Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Healthy | |
| Healthy | |
| Weak |
H's profitability and cash flow are currently healthy, and its revenue is stable, but its balance sheet is weak.
LCID Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Weak | |
| Weak | |
| Unavailable |
LCID's revenue is currently healthy, but its profitability and cash flow are weak. There isn't enough data to rate its balance sheet.
H PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 12x | $22.92 | -88% |
| Fair | 24x | $45.64 | -76% |
| Forward | 43x | $187 | — |
| Expensive | 78x | $151 | -20% |
| Current | 97x | $187 | — |
Historical ranges are pointers, not guarantees.
H's PE is in its expensive range at 97x. If earnings grow as analysts expect, today's price would be 43x next year's earnings.
LCID PE Valuation
LCID has no meaningful PE right now: it lost money over the past year.
H Forward outlook
| Metric | Outlook |
|---|---|
| Strongly improving | |
| Strong growth | |
| Growth | |
| Improving | |
| Moderate | |
| Low |
Analysts expect earnings and revenue growth for H, with profitability improving. However, they disagree widely on these estimates.
LCID Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Losses shrinking | |
| Strong growth | |
| -- | |
| Limited | |
| Low |
Analysts expect LCID's losses to shrink, with revenue growing. However, they disagree widely on these estimates.
H Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $4.37 | +125% |
| Q3 2026 | $1.94 | +$2.66 |
| Q2 2026 | $0.83 | -81% |
| Q1 2026 | -$0.34 | -104% |
| Q4 2025 | -$0.55 | -104% |
| Q3 2025 | -$0.72 | -105% |
| Q2 2025 | $4.42 | -52% |
| Q1 2025 | $7.91 | +23% |
| Q4 2024 | $12.65 | +517% |
H has the edge over LCID on earnings quality, reporting a profit while its opponent remains loss making.
LCID Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | -$13.08 | -$2.57 |
| Q2 2026 | -$13.65 | -$2.35 |
| Q1 2026 | -$13.15 | -$1.25 |
| Q4 2025 | -$12.09 | +$0.41 |
| Q3 2025 | -$10.51 | +$2.49 |
| Q2 2025 | -$11.30 | +$0.40 |
| Q1 2025 | -$11.90 | +$0.40 |
| Q4 2024 | -$12.50 | +$1.10 |
LCID is still losing money, but less than at its worst: $13.08 per share over the past year, against $16.50 at its worst in mid-2023.
H Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $1.7B | -2.4% |
| Q2 2026 | $1.8B | +1.2% |
| Q1 2026 | $1.7B | +1.7% |
| Q4 2025 | $1.8B | +12% |
| Q3 2025 | $1.8B | +9.6% |
| Q2 2025 | $1.8B | +6.2% |
| Q1 2025 | $1.7B | +0.2% |
| Q4 2024 | $1.6B | -3.5% |
H's revenue grew through 2023 and has held roughly level since: $1.7B last quarter, down 2.4% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 4.5% | +5.5 points |
| Q2 2026 | 10% | +7.8 points |
| Q1 2026 | 3.3% | +0.2 points |
| Q4 2025 | 0.5% | +3.5 points |
| Q3 2025 | -0.9% | -38 points |
| Q2 2025 | 2.1% | -25 points |
| Q1 2025 | 3% | -29 points |
| Q4 2024 | -3% | -3.5 points |
H has the edge over LCID on profitability, with a higher operating margin.
LCID Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $350.3M | +4.1% |
| Q2 2026 | $405.3M | +56% |
| Q1 2026 | $282.5M | +20% |
| Q4 2025 | $522.7M | +123% |
| Q3 2025 | $336.6M | +68% |
| Q2 2025 | $259.4M | +29% |
| Q1 2025 | $235M | +36% |
| Q4 2024 | $234.5M | +49% |
LCID has the edge over H on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | -245% | +35 points |
| Q2 2026 | -267% | +43 points |
| Q1 2026 | -350% | -56 points |
| Q4 2025 | -204% | +109 points |
| Q3 2025 | -280% | +105 points |
| Q2 2025 | -310% | +83 points |
| Q1 2025 | -294% | +128 points |
| Q4 2024 | -313% | +156 points |
LCID's operating margin was −245% last quarter, up 35 points from the same quarter a year ago, near the top of its range since 2020.
H Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$157M | -$68M |
| Q2 2026 | $28M | +$139M |
| Q1 2026 | $77M | -37% |
| Q4 2025 | $236M | +28% |
| Q3 2025 | -$89M | -$25M |
| Q2 2025 | -$111M | -182% |
| Q1 2025 | $123M | -41% |
| Q4 2024 | $184M | -41% |
H has the edge over LCID on cash generation, producing positive trailing cash flow while its opponent burns cash.
LCID Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$1B | -$84.2M |
| Q2 2026 | -$1.5B | -$463.2M |
| Q1 2026 | -$1.4B | -$849M |
| Q4 2025 | -$1.2B | -$417.1M |
| Q3 2025 | -$955.5M | -$333M |
| Q2 2025 | -$1B | -$271.6M |
| Q1 2025 | -$589.9M | +$125.1M |
| Q4 2024 | -$824.8M | -$77.6M |
LCID has burned cash in almost every quarter: −$5.2B over the past year, against −$3.4B the year before.
H Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -0.4% | -349K shares |
| 1 year | +0.9% | +835K shares |
| 3 years | -9.8% | -10.5M shares |
| 5 years | -7.3% | -7.6M shares |
| Available history | -9.4% | -9.9M shares |
H has the edge over LCID on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2026 | $147M |
| Q2 2026 | $12M |
| Q1 2026 | $135M |
| Q4 2025 | $114M |
| Q3 2025 | $30M |
| Q2 2025 | — |
| Q1 2025 | $149M |
| Q4 2024 | $11M |
H spent $408M buying back its own shares over the past year, up 115% from the year before.
LCID Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +3.3% | +12.5M shares |
| 1 year | +26% | +82.4M shares |
| 3 years | +73% | +166M shares |
LCID has 395M diluted shares, up 26% from a year ago.
| Quarter | Spent |
|---|---|
| Q4 2020 | $2.2M |
| Q1 2020 | — |
H Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 6.3x | High |
| Q2 2026 | 6.9x | High |
| Q1 2026 | 9.1x | High |
| Q4 2025 | 8.6x | High |
| Q3 2025 | 15.4x | High |
| Q2 2025 | 5.4x | High |
| Q1 2025 | 1.9x | Healthy |
| Q4 2024 | 1.5x | Healthy |
H's net debt is about 6.3 years of its operating earnings (EBITDA), down from 15 years a year ago.
LCID Net Leverage
LCID's operating earnings (EBITDA) were negative over the past year, so its debt can't be measured against them.
H Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 61.5 | Neutral |
| Stochastic | 79.4 | Neutral |
H's weekly RSI is 61 (neutral) and its Stochastic is 79 (neutral).
LCID Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 32.9 | Neutral |
| Stochastic | 7.1 | Oversold |
LCID's weekly RSI is 33 (neutral) and its Stochastic is 7 (oversold).
H PE vs Consumer Cyclical Sector
| Metric | H | Sector median | Relative |
|---|---|---|---|
| PE | 97x | 18x | 436% above |
| PE % | 89 | 47 | 42 pts above |
H is trading at 97x earnings, a 436% premium to the Consumer Cyclical sector's median of 18x.
LCID PE vs Consumer Cyclical Sector
LCID has no meaningful PE right now: it lost money over the past year.
H Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $171.6 | 9.1% above |
| 20 week MA | $175.2 | 6.9% above |
| 50 week MA | $169.8 | 10% above |
| 100 week MA | $155.2 | 21% above |
| 200 week MA | $143.0 | 31% above |
H has the edge over LCID on trend strength, trading above more of its moving averages.
LCID Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $3.53 | 7.9% below |
| 20 week MA | $4.88 | 33% below |
| 50 week MA | $7.33 | 56% below |
| 100 week MA | $15.4 | 79% below |
| 200 week MA | $31.9 | 90% below |
LCID is in a downtrend: it's below all five of its weekly moving averages, and 90% below its 200-week average.
H Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $90.7 | $72.8 | -20% |
| 2021 | $72.8 | $93.6 | +29% |
| 2022 | $93.6 | $91.1 | -2.7% |
| 2023 | $91.1 | $130.4 | +43% |
| 2024 | $130.4 | $158.5 | +22% |
| 2025 | $158.5 | $165.7 | +4.6% |
| 2026 YTD | $165.7 | $187.2 | +13% |
H has the edge over LCID on returns for 2026, with the stronger performance.
LCID Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $98.9 | $100.4 | +1.5% |
| 2021 | $100.4 | $376.4 | +275% |
| 2022 | $376.4 | $67.0 | -82% |
| 2023 | $67.0 | $42.1 | -37% |
| 2024 | $42.1 | $32.0 | -24% |
| 2025 | $32.0 | $11.4 | -64% |
| 2026 YTD | $11.4 | $3.25 | -72% |
LCID has finished four years in a row lower, and it's down 72% so far in 2026.